samarium Sm 153 lexidronam (Sm 153-EDTMP), samarium 153 complexed with ethylenediaminetetramethylenephosphonic acid, a bone-seeking diphosphonate complex that concentrates in areas of bone turnover. It is administered intravenously in the palliative treatment of patients with osteoblastic metastatic bone lesions.
